Distinguishing Allergic Conjunctivitis from Infectious Pink Eye
Itching is the single most reliable distinguishing feature: its presence strongly suggests allergic conjunctivitis, while its absence points toward infectious conjunctivitis 1, 2.
Key Clinical Differentiators
Allergic Conjunctivitis Features:
- Itching (most consistent and reliable sign) 1, 2
- Bilateral presentation with watery discharge
- Conjunctival chemosis (swelling)
- Eyelid edema
- Minimal to mild mucous discharge
- Periorbital hyperpigmentation ("allergic shiners") 3
- History of atopy or seasonal patterns
- Papillary reaction on palpebral conjunctiva 3
Infectious Conjunctivitis Features:
Bacterial:
- Mattering and adherence of eyelids on waking (strongest predictor) 1
- Purulent or mucopurulent discharge
- Lack of itching 1
- No history of previous conjunctivitis 1
- Unilateral or bilateral presentation
Viral:
- Watery discharge (most common overall cause of infectious conjunctivitis) 1
- Preauricular lymphadenopathy
- Often associated with upper respiratory symptoms
- Variable presentation at onset 1
Treatment Recommendations
For Allergic Conjunctivitis:
Start with topical antihistamines or dual-acting agents (antihistamine + mast cell stabilizer) as first-line pharmacotherapy 3, 1, 4.
- Non-pharmacological: artificial tears, cold compresses, allergen avoidance 4
- Pharmacological progression:
For Infectious Conjunctivitis:
Viral conjunctivitis requires only supportive care; bacterial conjunctivitis in uncomplicated cases is self-limited and does not require antibiotics 3, 1, 4.
However, topical antibiotics shorten duration and allow earlier return to work/school if treatment is desired 1.
Critical exceptions requiring immediate systemic antibiotics:
- Gonococcal conjunctivitis (vision-threatening, requires immediate systemic therapy) 3
- Chlamydial conjunctivitis (requires systemic + topical treatment) 1
- Contact lens wearers (risk of corneal involvement) 1, 6
Important Clinical Pitfalls
Avoid indiscriminate use of topical antibiotics or corticosteroids 3. The 2024 AAO guidelines explicitly state that viral conjunctivitis will not respond to antibacterial agents, and mild bacterial conjunctivitis is self-limited 3. Overuse contributes to antimicrobial resistance 6.
For severe allergic cases (vernal or atopic keratoconjunctivitis), topical corticosteroids are necessary to control symptoms 3, but chronic use requires ophthalmology co-management 2.
The evidence consistently shows that most infectious conjunctivitis cases resolve without intervention within 1-2 weeks 1, 4, making the distinction between allergic and infectious forms primarily important for symptom management and preventing unnecessary antibiotic use rather than preventing serious complications in typical cases.